アリゾナ州における胃癌の臨床試験
アリゾナ州内の拠点で、胃癌に関する13件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Mayo Clinic in Arizona - Phoenix, Phoenix
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
- Mayo Clinic, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07700979A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- HonorHealth Research Institute, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07705334Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Mayo Clinic Arizona, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #132, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06974110A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Mayo Clinic Hospital, Phoenix
- Mayo Clinic, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
- I-Mab Site 1016, Goodyear
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/14更新 · NCT07432295A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- HonorHealth Research Institute, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2024/02/08更新 · NCT04282044ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。